Uji klinis Lupus di New York
26 studi untuk Lupus mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50010, Brooklyn
- Sl0044 50264, Manhasset
- Sl0044 50077, New York
- dan 1 lainnya
Menerima pesertaFase 3
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05268289An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, New Hyde Park
- Research Site, New York
- Research Site, The Bronx
- dan 1 lainnya
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05835310Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- New York Medical College, Hawthorne
- NorthWell, New Hyde Park
Menerima pesertaFase 2
Usia 16 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
- Feinstein Institutes for Medical Research, Manhasset
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06987565HEALTH Home Urinalysis Testing
- NYU Langone Health, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07823478A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, New York
- Research Site, Syracuse
Menerima pesertaFase 1/2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- New York University School Of Medicine, New York
Menerima pesertaFase 4
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Kings County Hospital Center - Brooklyn, Brooklyn
Menerima pesertaStudi observasional
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Rochester, Rochester
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Icahn School of Medicine at Mount Sinai, New York
- State University of New York Upstate Medical Center (SUNY), Syracuse
Menerima pesertaFase 2
Usia 12 hingga 65 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07053800A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Northwell Health, Great Neck
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06570798Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- dan 2 lainnya
Menerima pesertaFase 3
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Fairport
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07260877Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07138898Trial of Belimumab in Early Lupus
- Feinstein Institute, Manhasset
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT03543839A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Columbia University Medical Center, New York
- University of Rochester Medical Center, Rochester
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT06613360A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US08-0, Syracuse
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
Menerima pesertaFase 1
Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06308978Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 45 · Wanita · Diperbarui 28 Apr 2026 · NCT00198068Alnuctamab for Refractory SLE (LATTE Study)
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT07219563Lupus Landmark Study: A Prospective Registry and Biorepository
- The Feinstein Institutes for Medical Research, Manhasset
- Columbia University Medical Center, New York
- Northwell Health, New York
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT05934149Safety of the Herpes Zoster Subunit Vaccine in Lupus
- NYU Langone Health, New York
Menerima pesertaFase 4
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 26 Des 2025 · NCT05559671Safety and Efficacy of ONT01 in Lupus
- Hospital for Special Surgery, New York
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Nov 2025 · NCT07107659Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.